Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 08:50:00 12/05/2026 pm IST			5-day change	1st Jan Change
296.50 ^DKK	-1.17%		+3.71%	-8.84%

09:21pm	Novo Nordisk A/S Demonstrates Higher Dose Wegovy Achieves Nearly 28% Weight Loss in Early Responders	CI
08:52pm	Dr. Reddy's to Launch Generic Ozempic in Canada This Month	MT

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,07,50,00,000	0	0	71.44 %
Stock B	1	3,39,00,00,000	3,18,98,57,691 ( 94.1 %)	2,65,52,791 ( 0.7833 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	17,75,60,500	5.238 %	7 589 M kr
NOVO NORDISK A/S 0.7444 %	2,52,37,791	0.7444 %	1 079 M kr
SEB Funds AB 0.2363 %	80,11,529	0.2363 %	342 M kr
Nykredit Bank A/S (Investment Management) 0.1651 %	55,98,160	0.1651 %	239 M kr
ODIN Forvaltning AS 0.1417 %	48,02,672	0.1417 %	205 M kr
Sjunde AP-fonden 0.1398 %	47,38,475	0.1398 %	203 M kr
State Street Global Advisors Ltd. 0.131 %	44,42,486	0.131 %	190 M kr
Nordea Investment Management AB 0.1259 %	42,67,282	0.1259 %	182 M kr
Eika Kapitalforvaltning AS 0.0844 %	28,61,072	0.0844 %	122 M kr
Capfi Delen Asset Management NV 0.0744 %	25,23,531	0.0744 %	108 M kr
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Bank of America Merrill Lynch Banco Multiplo SA 0.000131 %	35,400	0.000131 %	188 993 kr
Caixa DTVM SA 0.000011 %	2,870	0.000011 %	15 322 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,07,48,72,000	100 %	45 939 M kr
Anima Sgr SpA 0.0108 %	1,15,783	0.0108 %	5 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	17 309 kr

Name	Equities	%	Valuation
Loomis, Sayles & Co. LP 0.5054 %	1,71,35,384	0.5054 %	723 M kr
Fiduciary Trust Company International 0.4337 %	1,47,02,508	0.4337 %	621 M kr
Eaton Vance Management 0.3788 %	1,28,42,089	0.3788 %	542 M kr
Merrill Lynch International 0.3501 %	1,18,68,129	0.3501 %	501 M kr
Capital Research & Management Co. (International Investors) 0.3307 %	1,12,11,106	0.3307 %	473 M kr
Goldman Sachs Wealth Services LP 0.3242 %	1,09,91,430	0.3242 %	464 M kr
Folketrygdfondet 0.2998 %	1,01,64,137	0.2998 %	429 M kr
Fidelity Management & Research Co. LLC 0.2955 %	1,00,17,325	0.2955 %	423 M kr
T. Rowe Price International Ltd. 0.2858 %	96,88,262	0.2858 %	409 M kr
Fisher Asset Management LLC 0.2661 %	90,21,103	0.2661 %	381 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	47.62%
Other	1.5%
Novo Nordisk A/S	0.74%
State Street Corp.	0.18%
Markel Group, Inc.	0.08%
Cullen/Frost Bankers, Inc.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
SEI Investments Co.	0.01%
Analyst I.M.S. Investment Management Services Ltd.	0.01%
Unknown	49.83%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.95%
United States	7.37%
United Kingdom	1.19%
Norway	0.73%
Sweden	0.68%
Canada	0.48%
Germany	0.25%
Spain	0.19%
Belgium	0.15%
France	0.14%
Netherlands	0.14%
Switzerland	0.14%
Ireland	0.11%
Luxembourg	0.1%
Cayman Islands	0.08%
Finland	0.08%
Australia	0.06%
Italy	0.06%
Austria	0.04%
Israel	0.03%
Bermuda	0.03%
New Zealand	0.03%
Japan	0.02%
Singapore	0.02%
South Africa	0.02%
Hong Kong	0.02%
Mexico	0.01%
Portugal	0.01%
Iceland	0.01%
Liechtenstein	0.01%
Puerto Rico	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Employees

67,900

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company